United States newsroom

Myrbetriq is the first and only beta-3 adrenergic agonist indicated for the treatment of overactive bladder NORTHBROOK, Ill., June 28, 2012 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a...

Event Kicks Off Astellas' Annual Changing Tomorrow Day Volunteer Initiative KISSIMMEE, Fla., June 13, 2012 /PRNewswire/ -- Give Kids The World Village (GKTW) will host its largest single...

Japanese Pharmaceutical Company Expands in Glenview GLENVIEW, Ill. – June 4, 2012. Governor Pat Quinn today joined Astellas executives and more than 1,000 employees to open the company’s new...

Dose-Escalation Completed and Preliminary Antitumor Activity Observed Santa Monica, CA and Bothell, WA – June 4, 2012 – Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., and...

On May 21, 2012, the American Urological Association (AUA) issued the first guidelines specific to the diagnosis and treatment of overactive bladder (OAB) in the U.S. Astellas supports these new...

DEERFIELD, Ill., April 5, 2012 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that the Reproductive...

DEERFIELD, Ill., Feb. 21, 2012 /PRNewswire/ -- Astellas announces Charlotte M. E. Kremer, MD, MBA has joined the company as the head of one of the Company's newest organizations – Global Medical...

CARMEL, Calif. and DEERFIELD, Ill., Feb. 7, 2012 /PRNewswire/ -- Today, Science Buddies and Astellas USA Foundation ("Foundation") announced initiation of the Science Buddies-Astellas Rosalind...

SAN DIEGO, Calif. and Deerfield, Ill., December 21, 2011 — Zogenix, Inc. (NASDAQ: ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous...

Frank P. Hudson as Vice President of Finance Wolfgang Noe, Ph.D., as Vice President, Process Sciences and Manufacturing SANTA MONICA, Calif., Dec. 1, 2011 /PRNewswire/ -- Agensys, Inc....

More than 500 Astellas Employees Tackle Improvement Projects as Part of Company's Commitment to Service DEERFIELD, Ill., Sept. 23, 2011 /PRNewswire/ -- More than 500 employees from Astellas Pharma...

DEERFIELD, IL, September 15, 2010 – On January 1, 2011, the Donate Life float will roll through the streets of Pasadena reminding millions of viewers of the Rose Parade® to “Seize the Day”...

DEERFIELD, Ill., Aug. 15, 2011 /PRNewswire/ -- Astellas US, LLC ("Astellas") recently named Percival Barretto-Ko as Senior Vice President, Corporate Strategy and Government Affairs, a new position...

WHITEHOUSE STATION, N.J. and DEERFIELD, Ill., July 26, 2011 – Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Astellas US LLC ("Astellas"), the U.S. subsidiary of...

DEERFIELD, Ill., June 6, 2011 /PRNewswire/ -- Astellas Pharma Global Development, Inc., a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, today announced that it will be presenting data...

SOUTH SAN FRANCISCO, Calif. – June 2, 2011 – Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) and Astellas Pharma US, Inc. (“Astellas”), today announced results of...

DEERFIELD, Ill., May 19, 2011 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas") recently hired Mark Reisenauer as vice president of sales and marketing, oncology. Reporting directly to Patrick...

DEERFIELD, Ill., May 17, 2011 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas Pharma US"), U.S. subsidiary of Astellas Pharma Inc. (Tokyo: TSE: 4503, "the Company"), today announced the...

DEERFIELD, Ill., May 3, 2011 /PRNewswire/ -- Astellas Pharma Global Development, Inc. ("APGD"), a subsidiary of Astellas Pharma Inc. based in Tokyo, Japan, welcomes four seasoned industry leaders...

EURTAC is the First Phase III Study to Show Progression-Free Survival Benefit of First-Line Tarceva in a Western Population with Advanced Lung Cancer With EGFR Mutations SOUTH SAN FRANCISCO,...

Tokyo, – January 10, 2011 – Astellas Pharma Inc. (TSE: 4503) announced today that it has engaged Citigroup Global Markets Inc. to conduct, in conjunction with executive management, a review of...

48 Middle and Secondary School Science Teachers From Across the Country to Begin Year-long Professional Development Journey ARLINGTON, Va. — November 15, 2010 — The National Science Teachers...

TOKYO, Nov. 2, 2010 /PRNewswire/ -- Astellas Pharma Inc. ("Astellas"; headquarters: Tokyo; President and CEO: Masafumi Nogimori) announced that Donald B. Rice, PhD. will retire from Astellas...

CHICAGO and DEERFIELD, Ill., Nov. 2, 2010 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a research-based pharmaceutical company based in Deerfield, Ill., is pleased to donate 150 used...

K-12 Science Teachers and Parents Also Agree Outside Mentors and Use of Technology Resources Can Play an Important Role CHICAGO AND DEERFIELD, IL, October 28, 2010 – A new national survey...